GlassScriptPhysician profile
Samuel D Howard
NPI 1265095244
$11,923.97
in general payments reported to CMS, 2019-2025
10 companies · $6,611 in 2025
The $6,611 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $765 · 2021: $1,323 · 2022: $104 · 2023: $1,859 · 2024: $1,262 · 2025: $6,611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,342 · Food and Beverage: $3,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,342.27 |
| Food and Beverage | $3,389.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,249.33 | 2023-2025 | |
| Pinnacle, INC | $3,399.24 | 2020-2025 | |
| Stryker Corporation | $3,010.70 | 2022-2025 | Blueprint Patient Specific Instrumentation, Iconix, Aequalis Perform Reversed |
| Legacy Ortho LLC | $344.19 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $289.97 | 2024-2025 | Identity, Persona, Mymobility Platform |
| Heron Therapeutics, INC. | $250.32 | 2023 | Zynrelef |
| Smith+Nephew, INC. | $204.14 | 2021-2024 | Evos, Trigen Intertan |
| Miach Orthopaedics, INC. | $139.53 | 2025 | |
| Integra Lifesciences Corporation | $18.54 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $18.01 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.